| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-24397SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-27224 | |||
| BSA Free | NBP2-27223SS | |||
| Azide and BSA Free | NBP2-27224SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56457SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70374 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49891-0.1mg | |||
| BSA Free | NBP2-49891-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-22542-50ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72107 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64761-100ug | |||
| BSA Free | NB100-64761-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70345 | |||
![Immunohistochemistry-Paraffin: FoxP3 Antibody [NBP2-24397] - IHC analysis of formalin fixed paraffin-embedded (FFPE) human tonsil using FOXP3 antibody at 1:50 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Nuclear staining was observed. Staining was performed by Histowiz.](http://images.novusbio.com/fullsize/FoxP3-Antibody-Immunohistochemistry-Paraffin-NBP2-24397-img0002.jpg "Immunohistochemistry-Paraffin: FoxP3 Antibody [NBP2-24397] - IHC analysis of formalin fixed paraffin-embedded (FFPE) human tonsil using FOXP3 antibody at 1:50 on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images was performed using Aperio AT2 (Leica Biosystems). Nuclear staining was observed. Staining was performed by Histowiz.")
![Western Blot: FoxP3 Antibody [NBP2-24397] - Analysis of FOXP3 in (A) FOXP3 transfected and (B) mock transfected cell lysate using NBP2-24397 at 5 ug/ml.](http://images.novusbio.com/fullsize/FoxP3-Antibody-Western-Blot-NBP2-24397-img0003.jpg)
![Western Blot: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Analysis using Azide Free version of NBP2-27223. TNF alpha recombinant protein using TNF alpha antibody at 3 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-6N1E7-Western-Blot-NBP2-27223-img0004.jpg "Western Blot: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Analysis using Azide Free version of NBP2-27223. TNF alpha recombinant protein using TNF alpha antibody at 3 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![<b>Biological Strategies Validation. </b>Flow Cytometry: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Human PBMC were stimulated with PMA (10 ng/mL) and Ionomycin (500 ng/mL) for 5h in presence of Brefeldin A. At the end of stimulation, cells were surface stained before testing by intracellular staining. Fixed and permeabilized cells were incubated with 10 uL (0.5 ug) of TNF- alpha antibody for 30 minutes on ice. Lymphocyte population was gated for analysis to show TNF alpha positive T cells.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-6N1E7-Flow-Cytometry-NBP2-27223-img0002.jpg)
![Inhibition Activity: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Validation of inhibitory effects of TNF alpha antibody on TNF alpha activity in the cell line. NF-kB/SEAPorter cells were plated in 96-well plate at 5 x 10^4 cells per well for 16 h. Cells were pre-incubated with TNF alpha antibody at 10 and 20 ug/ml for 1 hr, then treated with 10 ng/ml TNF alpha or 10 ng/ml PMA. After 24h, the secreted alkaline phosphatase (SEAP) was analyzed using the SEAPorterAssay Kit . Image using the Azide Free format of this antibody.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-6N1E7-Inhibition-Activity-NBP2-27223-img0006.jpg)
![Western Blot: CD4 Antibody [NB100-56457] - Analysis of CD4 in human thymus lysate using this antibody at 2 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-Western-Blot-NB100-56457-img0002.jpg "Western Blot: CD4 Antibody [NB100-56457] - Analysis of CD4 in human thymus lysate using this antibody at 2 ug/ml.")
![Western Blot: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TNFRSF8.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Western-Blot-NBP2-46157-img0021.jpg "Western Blot: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TNFRSF8.")
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0020.jpg)
![Flow Cytometry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - (Blue).(1:100)](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Flow-Cytometry-NBP2-46157-img0022.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0001.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0002.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0003.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0004.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human bladder tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0005.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0006.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human bladder tissue..](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0007.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0008.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0009.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0010.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human Ovary tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0011.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0012.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0013.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0014.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0015.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0016.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0017.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human thyroid tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0018.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0019.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0009.jpg "Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.")
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse IgG1 isotype control. Figure B: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse anti-Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0001.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: RPE conjugated Rat anti-Dog CD4 and Mouse IgG1 isotype control labeled with Goat anti-Mouse FITC. Figure B: RPE conjugated Rat anti-Dog CD4 and Mouse anti-Dog CD3 labeled with Goat anti Mouse DyLight FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0002.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0003.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG2a isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD4.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0004.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0005.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0006.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG1 isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD8.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and purified Rat IgG2a isotype control detected with Goat anti Rat IgG2a DyLight 649. Figure B. FITC conjugated Mouse anti Canine CD3 and purified Mouse anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0008.jpg)
![Western Blot: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of 25 ug of Raji (Lane 1), Jurkat (Lane 2), and BAF-3 cell lysates (Lane 3) and a molecular weight protein ladder.](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Western-Blot-NBP2-22542-img0005.jpg "Western Blot: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of 25 ug of Raji (Lane 1), Jurkat (Lane 2), and BAF-3 cell lysates (Lane 3) and a molecular weight protein ladder.")
![Immunocytochemistry/Immunofluorescence: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 (green) showing staining in the cytoplasm of Raji cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Immunocytochemistry-Immunofluorescence-NBP2-22542-img0004.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in BAF-3 cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0003.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in PBMC cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0001.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in PBMC cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0002.jpg)
![Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Western-Blot-NBP2-45868-img0005.jpg "Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.")
![Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Paraffin-embedded Carcinoma of Human prostate tissue using anti-SLAMF7 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-Paraffin-NBP2-45868-img0006.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0001.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0002.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0003.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power")
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 followed by horseradish peroxidase conjugated Goat anti Mouse IgG1 as a detection reagent. Medium power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunohistochemistry-Paraffin-NB100-64761-img0002.jpg)
![Flow Cytometry: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Staining of Con A activated rat spleen cells with Mouse anti Rat CD25: Biotin](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Flow-Cytometry-NB100-64761-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody, red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. High power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0001.jpg)
![Western Blot: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD1c .](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Western-Blot-NBP2-46123-img0007.jpg "Western Blot: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD1c .")
![Immunocytochemistry/Immunofluorescence: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY CD1C.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunofluorescence-NBP2-46123-img0009.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0006.jpg)
![Western Blot: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Jurkat extracts (10ug).](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Western-Blot-NBP2-46123-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of HeLa cells.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunofluorescence-NBP2-46123-img0002.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0003.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0004.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0005.jpg)
![Western Blot: PD-L1 Antibody [NB300-903] - Staining of U2OS cell lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/PD-L1-Antibody-Western-Blot-NB300-903-img0002.jpg "Western Blot: PD-L1 Antibody [NB300-903] - Staining of U2OS cell lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: PD-L1 Antibody [NB300-903] - Immunofluorescence analysis of paraformaldehyde fixed U2OS cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/PD-L1-Antibody-Immunocytochemistry-Immunofluorescence-NB300-903-img0004.jpg)
![Flow Cytometry: PD-L1 Antibody [NB300-903] - Flow cytometric analysis of paraformaldehyde fixed Jurkat cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/PD-L1-Antibody-Flow-Cytometry-NB300-903-img0005.jpg)
![Western Blot: PD-L1 Antibody [NB300-903] - Staining of Human Heart lysate (35 ug protein in RIPA buffer). Antibody at 0.01 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/PD-L1-Antibody-Western-Blot-NB300-903-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: PD-L1 Antibody [NB300-903] - Immunofluorescence analysis of paraformaldehyde fixed AA431 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/PD-L1-Antibody-Immunocytochemistry-Immunofluorescence-NB300-903-img0003.jpg)
![Western Blot: CD14 Antibody [NB100-2807] - Staining (1ug/ml) of PBM lysate (35ug protein in RIPA buffer) with (B) and without (A) blocking with the immunizing peptide. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/CD14-Antibody-Flow-Cytometry-NB100-2807-img0006.jpg "Western Blot: CD14 Antibody [NB100-2807] - Staining (1ug/ml) of PBM lysate (35ug protein in RIPA buffer) with (B) and without (A) blocking with the immunizing peptide. Detected by chemiluminescence.")
![Flow Cytometry: CD14 Antibody [NB100-2807] - Flow cytometric analysis of paraformaldehyde fixed A549 cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CD14-Antibody-Flow-Cytometry-NB100-2807-img0005.jpg)
![Immunohistochemistry: Goat Polyclonal CD14 Antibody [NB100-2807] - (8µg/ml) staining of paraffin embedded Human Tonsil. Heat induced antigen retrieval with citrate buffer pH 6, HRP-staining.](http://images.novusbio.com/fullsize/antibody/nb100-2807_goat-polyclonal-cd14-antibody-imgenex-img-3991-immunohistochemistry-283202413831..jpg)
![Control: Goat Polyclonal CD14 Antibody [NB100-2807] - Negative Control showing staining of paraffin embedded Human Tonsil, with no primary antibody.](http://images.novusbio.com/fullsize/antibody/nb100-2807_goat-polyclonal-cd14-antibody-imgenex-img-3991-control-283202413949..jpg)
![Western Blot: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Western blot analysis of extracts of various cell lines, using HLA DQA1 Rabbit mAb (NBP3-15364) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Western-Blot-NBP3-15364-img0004.jpg "Western Blot: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Western blot analysis of extracts of various cell lines, using HLA DQA1 Rabbit mAb (NBP3-15364) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Immunohistochemistry of paraffin-embedded mouse spleen using HLA DQA1 Rabbit mAb (NBP3-15364) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Immunohistochemistry-Paraffin-NBP3-15364-img0003.jpg)
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Immunohistochemistry of paraffin-embedded rat spleen using HLA DQA1 Rabbit mAb (NBP3-15364) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Immunohistochemistry-Paraffin-NBP3-15364-img0001.jpg)
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Immunohistochemistry of paraffin-embedded human spleen using HLA DQA1 Rabbit mAb (NBP3-15364) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Immunohistochemistry-Paraffin-NBP3-15364-img0002.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Mouse liver tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-52202517172868.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Mouse spleen tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-52202517172834.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Rat spleen tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-5220251725197.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Human liver tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-5220251726030.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Human colon tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-52202517202942.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Human tonsil tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-5220251718958.jpg)